Podcasts about current evidence

In this week's episode, Dani continues her conversation with Dr Sarah Glynne, GP, menopause specialist, and co-author of the new paper “Menopausal Hormone Therapy for Breast Cancer Patients: What Is the Current Evidence?” - to explore one of the most frequently asked questions left after last week's episode: testosterone therapy after breast cancer.This is Part 2 of our special series following the publication of the new paper.In this episode, Dani and Dr Glynne discuss:What testosterone actually does for energy, mood, and libido.The studies we have so far - and how reliable they are.Whether testosterone can convert into oestrogen.How testing works and when it might be appropriate.Whether testosterone therapy can or should be used alongside endocrine treatments.The paper is here: https://journals.lww.com/menopausejournal/fulltext/9900/menopausal_hormone_therapy_for_breast_cancer.532.aspxThe Meno ABS trial: https://www.londonbreastcancer.com/meno-abc-trialFind Dr Glynne here https://www.clairemellon.co.uk/dr-sarah-glynneThe episode on testosterone with Dr Rebecca Glaser is Ep 56The episode with a patient on testosterone therapy is Ep 97Read all about HRT after breast cancer in Dani's book “Navigating Menopause After Cancer' in chapter 6: Buy it here: https://amzn.eu/d/0uLveeE Episode Highlights:00:00 Intro03:34 "Testosterone Use in Women"06:16 Testosterone Debate: Data vs. Choice10:38 Menopause Consultation & Treatment Approaches17:45 "Testosterone After Breast Cancer"21:21 Complexity of Menopause Treatment Conversations23:49 Vaginal OestrogenConnect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

In this week's episode of The Menopause and Cancer Podcast, Dani speaks with two of the authors behind the new paper, Menopausal hormone therapy for breast cancer patients: what is the current evidence? Professor Jayant Vaidya, Consultant Oncoplastic Breast Surgeon, and Dr Sarah Glynne, GP and menopause specialist.This is the first of a two-part special exploring what this new paper and upcoming MENO-ABC clinical trial could mean for breast cancer survivors curious about HRT or already on HRT.Up until recently, most experts thought a study like this would never happen — but it's happening.Together, they unpack:What's new about this paper — and why it matters.The scientific and ethical concept of equipoise (yes, Dani learned a new word!).How the new MENO-ABC trial could change what we know about HRT use after breast cancer.What this research might mean for patients, clinicians, and the future of survivorship care.Next week: Don't miss part two, where Dani and Dr Sarah Glynne take a deep dive into testosterone use after breast cancer — what we know, what we don't, and where the conversation is heading.Links & Resources:The paper: https://journals.lww.com/menopausejournal/fulltext/9900/menopausal_hormone_therapy_for_breast_cancer.532.aspxThe trial: https://www.londonbreastcancer.com/meno-abc-trialFind Dr Glynne here https://www.clairemellon.co.uk/dr-sarah-glynneFind Professor Vaidya here https://professorvaidya.co.uk/Watch Dani's 5-part Youtube series on HRT after breast cancer, start here: https://www.youtube.com/watch?v=heTF5ufX59Y&list=PLsUEBZ4ZwowpAQ1ueFUHlzDvzAtD_hyQr&index=6 Episode Highlights:00:00 Intro08:01 "HRT Debate and Its Impact"09:48 Evidence-Based Breast Cancer Trial13:46 Advances in Breast Cancer Treatment16:43 HRT Risks Post-Breast Cancer20:52 Oestrogen Risks in Cancer Relapse23:17 "Clinical Trial Equipoise Explained"29:00 "Expert Consensus and Criticism"29:47 Collaborative Review Strengthened Research32:52 Breaking Shame Through Conversations36:04 Weighing Risks for Quality Life41:57 "Prioritising Quality Over Longevity"43:08 HRT and Breast Cancer Relapse RiskRead all about HRT after breast cancer in Dani's book “Navigating Menopause After Cancer' in chapter 6: Buy it here: https://amzn.eu/d/0uLveeE

Dr. Amy Yorke, PT, PhD, board-certified clinical specialist in neurology, joins host J.J. Mowder-Tinney for an energizing discussion on what it really takes to move evidence into practice. Together, they explore the everyday barriers rehab professionals face, such as time, resources, and habits, and offer practical strategies to help you implement evidence without losing clinical creativity. With examples from Amy's own work in a student-led pro bono clinic, you'll walk away inspired to start small, think critically, and share what you learn. If you've ever felt the tug between research and real life, this episode is for you.Learning ObjectivesAnalyze current evidence on knowledge translation in rehabilitation practiceApply practical, evidence-based strategies to bridge the research-to-practice gapImplement clinical practice guidelines through real-world case scenariosTimestamps(00:00:00) Welcome(00:00:05) Bridging research and practice(00:01:29) Amy's journey into knowledge translation(00:04:12) The importance of evidence in practice(00:08:50) Challenges in implementing evidence-based practice(00:09:36) Adapting evidence to local contexts(00:10:35) The role of patient values in evidence-based practice(00:13:10) The human element in clinical practice(00:14:58) Overcoming barriers to change(00:17:19) Facilitators and barriers in knowledge translation(00:22:10) Creating a supportive environment for evidence use(00:24:50) Innovative podcast ideas for therapists(00:26:05) Bridging gaps in clinical practice guidelines(00:28:05) The role of learning health systems in rehab(00:31:17) Collaborative approaches in neuro rehab(00:33:10) Engaging patients in their recovery(00:37:08) Overcoming barriers to patient engagement(00:40:15) Action steps for clinicians(00:41:55) Real-world application of evidence-based practice(00:47:00) Fun wrap-up and superpower dreams:Neuro Navigators is brought to you by Medbridge. If you'd like to earn continuing education credit for listening to this episode and access bonus takeaway handouts, log in to your Medbridge account and navigate to the course where you'll find accreditation details. If applicable, complete the post-course assessment and survey to be eligible for credit. The takeaway handout on Medbridge gives you the key points mentioned in this episode, along with additional resources you can implement into your practice right away.To hear more episodes of Neuro Naviagators, visit ⁠⁠⁠⁠⁠⁠https://www.medbridge.com/neuro-navigators⁠⁠⁠⁠⁠⁠If you'd like to subscribe to Medbridge, visit ⁠⁠⁠⁠⁠⁠https://www.medbridge.com/pricing/⁠⁠⁠⁠⁠⁠IG: ⁠⁠⁠https://www.instagram.com/medbridgeteam/

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Dr. Reaves and Dr. Sarnak on "Benefits and risks of intensive blood pressure control in CKD patients: what does the current evidence tell us?" from nephSAP Vol 24, No 2.

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Dr. Reaves and Dr. Sarnak on "Benefits and risks of intensive blood pressure control in CKD patients: what does the current evidence tell us?" from nephSAP Vol 24, No 2.

CME credits: 0.25 Valid until: 06-06-2026 Claim your CME credit at https://reachmd.com/programs/cme/nonsteroidal-mra-sglt2i-in-people-with-ckd-t2d-current-evidence-and-rationale-for-combination-therapy/29909/ Can combining a nonsteroidal MRA and an SGLT2 inhibitor unlock new clinical potential for patients with type 2 diabetes and chronic kidney disease (CKD)? In this expert discussion, Dr. Jennifer Green and Dr. Hiddo Heerspink review the latest findings from the CONFIDENCE trial, which demonstrated a significant additive reduction in albuminuria—an important surrogate marker for kidney and cardiovascular risk—when finerenone and empagliflozin are used together. They explore the clinical rationale behind combination therapy, address persistent challenges in CKD detection, and consider the practical implications for implementing these therapies in high-risk populations.=

CME credits: 0.25 Valid until: 06-06-2026 Claim your CME credit at https://reachmd.com/programs/cme/nonsteroidal-mra-sglt2i-in-people-with-ckd-t2d-current-evidence-and-rationale-for-combination-therapy/29909/ Can combining a nonsteroidal MRA and an SGLT2 inhibitor unlock new clinical potential for patients with type 2 diabetes and chronic kidney disease (CKD)? In this expert discussion, Dr. Jennifer Green and Dr. Hiddo Heerspink review the latest findings from the CONFIDENCE trial, which demonstrated a significant additive reduction in albuminuria—an important surrogate marker for kidney and cardiovascular risk—when finerenone and empagliflozin are used together. They explore the clinical rationale behind combination therapy, address persistent challenges in CKD detection, and consider the practical implications for implementing these therapies in high-risk populations.=

En lo último en salud y fitness edición de marzo 2025, damos un paseo por las últimas tendencias, investigaciones y noticias en el mundo de la salud y el fitness. En esta edición tenemos un menú variado: vamos a ver qué dice la ciencia sobre proteína animal vs vegetal para ganar músculo, cómo el ejercicio regular puede ayudarte a mantener la inflamación a raya conforme envejeces, y por qué más cafeína no siempre significa mejor rendimiento. También analizaremos si el alpha-GPC realmente mejora tu desempeño mental y físico, y veremos qué hay de cierto en eso de que el té verde protege tu cerebro.   Atajos del Episodio 02:05 -¿Es mejor la proteína animal o vegetal para ganar músculo?1 05:00 – El ejercicio durante toda la vida puede contrarrestar la inflamación crónica asociada con la edad2 09:21 – Más cafeína no siempre es mejor: lo que un grupo de kickboxers nos enseñó3 12:21 – ¿Alpha-GPC mejora el rendimiento mental y físico? La ciencia aún no está convencida4 15:56 – ¿El té verde protege tu cerebro? La ciencia dice que sí, pero con reservas5   Referencias:  1.      Reid-McCann, R. J., Brennan, S. F. & Ward…, N. A. Effect of Plant Versus Animal Protein on Muscle Mass, Strength, Physical Performance, and Sarcopenia: A Systematic Review and Meta-analysis of Randomized …. Nutrition … (2025). 2.      Pérez-Castillo, I. M., Rueda, R. & Bouzamondo…, H. Does Lifelong Exercise Counteract Low-Grade Inflammation Associated with Aging? A Systematic Review and Meta-Analysis. Sports Medicine (2025). 3.      Saremi, M., Shahriari, F. & Hemmatinafar…, M. Low-Dose Caffeine Supplementation Is a Valuable Strategy for Increasing Time to Exhaustion, Explosive Power, and Reducing Muscle Soreness in …. Current Developments … (2025). 4.      Kerksick, C. M. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men. Nutrients (2024). 5.      Zhou, S., Zhu, Y., Ren, N., Wu, M. & Liu, Y. The Association Between Green Tea Consumption and Cognitive Function: A Meta-Analysis of Current Evidence. Neuroepidemiology (2025).

The study “The Physiological Effects of Weight-Cycling: A Review of Current Evidence” published January 3, 2025 is making broad claims that “healthy individuals who struggle with overw*ight or ob*sity should not be discouraged from repeated attempts to lose the excess weight.” In part 1 we looked at the issues with the authors and the premise. In part 2 we looked at the issues with the studies they included, in this final part we'll discuss the issues with their interpretation and conclusions. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

We are back discussing the article “The Physiological Effects of Weight-Cycling: A Review of Current Evidence” published January 3, 2025. In part 1 we looked at the authors and the introduction, in part 2 we'll be looking at the studies they included. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

As more data has come out about the realities of GLP-1s for weight loss (including some people regaining weight while still taking the drug, and research showing that those who go off the drugs regain weight quickly, paired with their own research showing that by year four, 89.5% of patients were no longer on the drug,) there has been talk about the dangers posed by drug-induced weight cycling. As we've seen with other concerns around these drugs and intentional weight loss in general (like eating disorders,) suddenly I'm seeing articles and studies trying to minimize the concerns about weight cycling.Enter “The Physiological Effects of Weight-Cycling: A Review of Current Evidence” published January 3, 2025. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

#484: Can your baby eat enough to meet their nutrition needs if you skip spoon-feeding? Researcher Kinzie Matzeller discusses her recent research about baby-led weaning and whether or not it actually works. Listen to this episode to learn: What the existing body of research says about baby-led weaning…and why doctors still say they aren't sure if it “works” How Kinzie analyzed existing publications about baby-led weaning in her review article recently published in Nutrients Why researchers in infant feeding often say “more research is needed” instead of doing that actual research themselves Shownotes for this episode can be found here: https://www.babyledweaning.co/podcast/484 Links from this episode: Matzeller, Kinzie L et al. “Current Evidence on Nutrient Intakes and Infant Growth: A Narrative Review of Baby-Led Weaning vs. Conventional Weaning.” Nutrients vol. 16,17 2828. 23 Aug. 2024, doi:10.3390/nu16172828 Baby-Led Weaning with Katie Ferraro program with the 100 First Foods™ Daily Meal Plan, join here: https://babyledweaning.co/program  Baby-Led Weaning for Beginners free online workshop with 100 First Foods™ list to all attendees, register here: https://babyledweaning.co/baby-led-weaning-for-beginners Other Episodes Related to this Topic Episode 70 - The Evidence Behind Baby-Led Weaning with Amy Brown, PhD Episode 473 - Is Baby-Led Weaning Safe? A Deep Dive into Current Research

#484: Can your baby eat enough to meet their nutrition needs if you skip spoon-feeding? Researcher Kinzie Matzeller discusses her recent research about baby-led weaning and whether or not it actually works. Listen to this episode to learn: What the existing body of research says about baby-led weaning…and why doctors still say they aren't sure if it “works” How Kinzie analyzed existing publications about baby-led weaning in her review article recently published in Nutrients Why researchers in infant feeding often say “more research is needed” instead of doing that actual research themselves Shownotes for this episode can be found here: https://www.babyledweaning.co/podcast/484 Links from this episode: Matzeller, Kinzie L et al. “Current Evidence on Nutrient Intakes and Infant Growth: A Narrative Review of Baby-Led Weaning vs. Conventional Weaning.” Nutrients vol. 16,17 2828. 23 Aug. 2024, doi:10.3390/nu16172828 Baby-Led Weaning with Katie Ferraro program with the 100 First Foods™ Daily Meal Plan, join here: https://babyledweaning.co/program  Baby-Led Weaning for Beginners free online workshop with 100 First Foods™ list to all attendees, register here: https://babyledweaning.co/baby-led-weaning-for-beginners Other Episodes Related to this Topic Episode 70 - The Evidence Behind Baby-Led Weaning with Amy Brown, PhD Episode 473 - Is Baby-Led Weaning Safe? A Deep Dive into Current Research

In this informative episode, Nurse Doza explores the complexities of Hashimoto's thyroiditis, an autoimmune disorder affecting the thyroid. He delves into the root causes beyond just thyroid dysfunction, discusses manageable lifestyle changes, highlights the liver's crucial role, and emphasizes the importance of targeted supplementation. This comprehensive overview provides practical insights for those living with Hashimoto's, offering hope and actionable steps towards better health. 5 KEY TAKEAWAYS Hashimoto's often stems from previous infections, traumatic events, or lifestyle factors, not just thyroid issues. A gluten-free diet can significantly reduce thyroid antibodies associated with Hashimoto's. Managing stress is crucial, as it can trigger Hashimoto's flare-ups. The liver plays a vital role in thyroid hormone conversion and function. Targeted supplementation, especially zinc, selenium, and liver support, can improve Hashimoto's management. FEATURED PRODUCT Double the power with our Liver Boost and Berberine plus combo. This powerful duo is designed to support optimal liver function and metabolic health—key factors in managing Hashimoto's thyroiditis as discussed in this episode. By enhancing liver health, you can potentially improve thyroid hormone conversion and reduce inflammation, addressing the root causes of Hashimoto's beyond just thyroid function. SHOP HERE   TIMESTAMPS 00:00 START 01:00 Introduction to Hashimoto's thyroiditis 02:00 Previous infections and their role in Hashimoto's 05:00 Traumatic events and thyroid health 08:00 Importance of proper thyroid testing 11:00 Gluten's impact on thyroid health 14:00 Managing Hashimoto's through lifestyle changes 17:00 The liver's role in thyroid function 20:00 Nutrient deficiencies affecting thyroid health 22:00 Benefits of dry sauna for Hashimoto's 24:00 Importance of supplements in managing Hashimoto's   RESOURCES "Viruses and thyroiditis: an update" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654877/ "Posttraumatic stress disorder and risk of selected autoimmune diseases among US military personnel" https://pubmed.ncbi.nlm.nih.gov/30488818/ "Nutritional Approach to Thyroid Health: An Overview of the Current Evidence" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101513/ "Hashimoto Thyroiditis: An Update on Pathogenic Mechanisms, Diagnostic Protocols, Therapeutic Strategies, and Potential Malignant Transformation" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478900/ "Thyroid Hormones and the Liver: A Regulatory Network" https://link.springer.com/article/10.1007/s40618-020-01208-6 "The interrelationship between thyroid gland and liver: a review" https://www.sciencedirect.com/science/article/abs/pii/S0300508921006064 "Far-infrared therapy for cardiovascular, autoimmune, and other chronic health problems: A systematic review" https://onlinelibrary.wiley.com/doi/10.1155/2018/1857413  

[Video available on YouTube] Welcome back to Diary of a Drop-Out, with me, Naomi Balderson. I realised I haven't been open with you about what I'm actually doing at the moment. In this episode I give you a life update, explain the history of psychedelics, the science and what I believe my role is in the ‘renaissance'. I want to give you the most authentic expression of me, every time you tune in. I am birthing my business and putting on psychedelic integration circles, through doing so I realised a lot of people are unaware of this whole subject. Therefore, I hope this episode can be comprehensive and broad summary of the field and what I feel my role is in it. From sitting in my first year uni halls, feeling like I have no purpose or ambition in life to now; knowing that this is my calling in every bone of my body. Thank you for listening and continuing to support me. All my love, Naomi x Jersey Integration Circle 11/08 https://www.eventbrite.com/e/psychedelic-integration-sharing-circle-tickets-945480707247?aff=oddtdtcreator Disclaimer: I do not condone the use of illegal or controlled substances. The content shared is based on personal experiences and does not constitute medical advice. The host is not a medical professional, and listeners are encouraged to seek guidance from qualified healthcare professionals regarding any personal health concerns or decisions. This podcast aims to provide information and entertainment, and the views expressed are those of the individuals involved. SOCIALS AND LINKS  Instagram: Naomi's Instagram | Diary of a Drop-Out Instagram   TikTok: Diary of a Drop-Out TikTok  Youtube: Subscribe here  Spotify: Follow and rate the show here If you want to ask me questions, need advice, or have any episode ideas, submit here: DOAD Community Google Form Business enquiries: Naomi@mayura.je Vital 12 month Psychedelic Training Program Affiliate Link https://psychedelicstoday.teachable.com/a/aff_3ypstxyw/external?affcode=80460_zyftb8kq REFERENCES: (in order of appearance)  Blue lotus https://www.acslab.com/wellness/blue-lotus-history-effects-products Indigenous Philosophies and the "Psychedelic Renaissance" https://anthrosource.onlinelibrary.wiley.com/doi/10.1111/anoc.12161 Ethical principles of traditional Indigenous medicine to guide western psychedelic research and practice https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950658/ Albert Hofmann https://www.britannica.com/biography/Albert-Hofmann R. Gordon Wasson and the Publicity Campaign to Introduce Magic Mushrooms to Mid-Century America https://www.cairn.info/revue-francaise-d-etudes-americaines-2018-3-page-91.htm?ref=doi How the Vietnam War Empowered the Hippie Movement https://www.history.com/news/vietnam-war-hippies-counter-culture The Past and Future of Psychedelic Science: An Introduction to This Issue https://pubmed.ncbi.nlm.nih.gov/31132970/ MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660711/ Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study https://pubmed.ncbi.nlm.nih.gov/27210031/ Therapeutic effect of psilocybin in addiction: A systematic review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947277/ Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study https://pubmed.ncbi.nlm.nih.gov/28402682/ Psilocybin in Palliative Care: An Update https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106897/ Examining Psychedelic-Induced Changes in Social Functioning and Connectedness  https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2021.749788/full The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2018.00007/full

Jacob och Caroline diskuterar jojo-bantning i avsnitt 123 av Hälsoveckan by Tyngre. Som utgångspunkt använder de sig av artikeln ”The Physiological Effects of Weight-Cycling: A Review of Current Evidence” men utöver det så blir det också en ordentlig diskussion kring problemet med att veta vad som orsakar vad i observationsstudier och bristen på bra studier kring en fråga som är högst relevant för väldigt många. På Hälsoveckan by Tyngres instagram kan du hitta bilder relaterat till detta och tidigare avsnitt. Hålltider (00:00:00) Introsnack (00:01:33) Dagens ämne är jojo-bantning

ADHD is the most common neurodevelopmental disorder in children under 18. The prevalence of ADHD is rising dramatically, with 1 in 20 children being on behavior modifying medications such as Adderall and Ritalin. These are medications that act as central nervous system stimulants, and can cause nervousness, agitation, anxiety, insomnia, vomiting, mood swings, an increased heart rate, increased blood pressure and even psychosis in susceptible individuals. Most research indicates the increase in ADHD is directly linked to poor gut health, the food that children eat, how they sleep and even how they breath. Join us in this episode as we explore natural alternatives for ADHD including diet, lifestyle, and supplements, that can help your kids (and adults) focus better and beat hyperactivity. Citations 1. Checa-Ros A, Jeréz-Calero A, Molina-Carballo A, Campoy C, Muñoz-Hoyos A. Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients. 2021;13(1):249. Published 2021 Jan 16. doi:10.3390/nu13010249 2. Altun H, Şahin N, Belge Kurutaş E, Güngör O. Homocysteine, Pyridoxine, Folate and Vitamin B12 Levels in Children with Attention Deficit Hyperactivity Disorder. Psychiatr Danub. 2018;30(3):310-316. doi:10.24869/psyd.2018.310 3. Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015;29(6):2207-2222. doi:10.1096/fj.14-268342 4. Meg St-Esprit McKivigan. Nature Deficit Disorder is Really a Thing. June 23, 2020. The New York Times. https://www.nytimes.com/2020/06/23/parenting/nature-health-benefits-coronavirus-outdoors.html?smid=url-share --- Support this podcast: https://podcasters.spotify.com/pod/show/elanie-welch/support

On Episode 36 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the January 2024 issue of Stroke: “Time Window for Induced Hypertension in Acute Small Vessel Occlusive Stroke With Early Neurological Deterioration” and “Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence.” She also interviews Drs. Kelly Flemming and Issam Awad about their articles “Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage. Part I: Event Rates and Clinical Outcome” and “Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage. Part II: Biomarkers and Trial Modeling.” For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20240108.294731

There's a common misconception that you shouldn't take probiotics for SIBO.   Where this comes from is the thought that adding bacteria to a bacterial overgrowth must be a bad idea.   But this overlooks how probiotics actually work AND the plethora of data we have on probiotics for SIBO.  So let's dive in to see what all the data actually means.    Read/Watch Next The Ultimate 3-Step SIBO Treatment Guide: https://drruscio.com/sibo-treatments/  Your Guide to Choosing the Right SIBO Diet: https://drruscio.com/sibo-diet/  SIBO, Probiotics & Your Gut: A Long-Term Strategy: https://drruscio.com/sibo-probiotics/    Featured Studies  Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants: https://pubmed.ncbi.nlm.nih.gov/23703468/  Saccharomyces boulardii and infection due to Giardia lamblia: https://pubmed.ncbi.nlm.nih.gov/16798698/  Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194055/ Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study: https://pubmed.ncbi.nlm.nih.gov/36630947/ Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth: https://pubmed.ncbi.nlm.nih.gov/29508268/ Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease: https://pubmed.ncbi.nlm.nih.gov/25244414/ [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study]: https://pubmed.ncbi.nlm.nih.gov/21381407/ Bacillus clausii as a treatment of small intestinal bacterial overgrowth: https://pubmed.ncbi.nlm.nih.gov/19352343/ Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence: https://pubmed.ncbi.nlm.nih.gov/28267052/    Timestamps 00:00 Intro  00:46 How probiotics actually work in the body 02:33 Probiotic type 1: S. boulardii  04:08 Probiotic type 2: Lacto-Bifido  07:13 Probiotic Type 3: Soil-based  09:12 The protocol    Get the Latest Updates Facebook - https://www.facebook.com/DrRusciodc Instagram - https://www.instagram.com/drrusciodc/ Pinterest - https://www.pinterest.com/drmichaelrusciodc  DISCLAIMER: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Music featured in this video: "Modern Technology" by Andrew G, https://audiojungle.net/user/andrew_g  *Full transcript available on YouTube by clicking the “Show transcript” button on the bottom right of the video.

If you use the right therapies at the right time, there's an 85% resolution rate for SIBO.  I'll share which SIBO treatments are effective and, most importantly, how and when to do them to get the best results.    Watch/Read Next… What is SIBO? https://www.youtube.com/watch?v=3OjefHfOx2I  Low FODMAP guides: https://drruscio.com/getlowfodmapguide/  Monash low  FODMAP app: https://www.monashfodmap.com/ibs-central/i-have-ibs/get-the-app/  Biota Clear 1A: https://store.drruscio.com/products/biota-clear-1a  Elemental Heal: https://bit.ly/48Y2vuk  My articles: https://drruscio.com/blog/ My book: https://drruscio.com/getgutbook/  Courses, free guides, and more: https://drruscio.com/resources?utm_source=youtube&utm_medium=link&utm_campaign=drruscio.com_resources   Featured Studies  The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions: https://pubmed.ncbi.nlm.nih.gov/31344510/ Epidemiology of small intestinal bacterial overgrowth: https://pubmed.ncbi.nlm.nih.gov/37389240/ Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis: https://pubmed.ncbi.nlm.nih.gov/29761234/ Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis: https://pubmed.ncbi.nlm.nih.gov/29915215/ Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD: https://pubmed.ncbi.nlm.nih.gov/36364824/ Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis: https://pubmed.ncbi.nlm.nih.gov/34376515/ Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study: https://pubmed.ncbi.nlm.nih.gov/36630947/ Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth: https://pubmed.ncbi.nlm.nih.gov/29508268/ Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence: https://pubmed.ncbi.nlm.nih.gov/28267052/ Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth: https://pubmed.ncbi.nlm.nih.gov/24004101/  Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth: https://pubmed.ncbi.nlm.nih.gov/24891990/ A 14-day elemental diet is highly effective in normalizing the lactulose breath test: https://pubmed.ncbi.nlm.nih.gov/14992438/  Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics: https://pubmed.ncbi.nlm.nih.gov/30483563/  Efficacies of prokinetics and rifaximin on the positivity of a glucose breath test in patients with functional dyspepsia: a randomized trial: https://pubmed.ncbi.nlm.nih.gov/35748472/    Timestamps 00:00 Intro  01:13 What is SIBO? 03:01 Labs and symptoms don't always match 03:41 The diet to start with 07:55 Probiotics  11:56 Antibiotics  12:28 Herbal therapies  14:06 The elemental diet 17:26 Prokenetics    Get the Latest Updates Facebook - https://www.facebook.com/DrRusciodc Instagram - https://www.instagram.com/drrusciodc/ Pinterest - https://www.pinterest.com/drmichaelrusciodc  DISCLAIMER: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Music featured in this video: "Modern Technology" by Andrew G, https://audiojungle.net/user/andrew_g  *Full transcript available on YouTube by clicking the “Show transcript” button on the bottom right of the video.

Natalie Gukasyan, M.D., psychiatrist and Medical Director at Johns Hopkins University Center for Psychedelic and Consciousness Research in Baltimore, MD, presents a lecture on "Psychedelic-Assisted Therapy: Overview of Treatment Model and Current Evidence for Efficacy."

In this Healthed lecture, pain expert Joyce McSwan puts NSAIDs in perspective - effectiveness, safety and the difference between the different formulations including the topical treatments.See omnystudio.com/listener for privacy information.

Partnerem odcinka jest firma Sanprobi #współpracareklamowaW 136. odcinku podcastu rozmawiam z dr n. farm. Nataszą Staniak, specjalistką w dziedzinie neuropsychofarmakologii i ekspertką probiotykoterapii. Dyskutujemy głównie o wpływie mikrobioty na nadwagę i otyłość.Odsłuchaj nagrania, jeśli chcesz dowiedzieć się:Co wpływa na to, że jemy więcej niż potrzebujemyJaki jest wpływ mikrobioty na metabolizm i wchłanianie składników pokarmowychDlaczego niektóre osoby mogą jeść więcej i nie tyjąJak zadbać o zdrową mikrobiotę jelitowąJakie są różnice w mikrobiocie osób szczupłych i otyłychJaki wpływ ma stan zapalny na masę ciałaJak mikrobiota wpływa na apetytCzy antybiotykoterapia wpływają na ryzyko wystąpienia otyłościDlaczego Akkermansia muciniphila jest szczególną bakterią dla naszego zdrowiaCzy probiotykoterapia może wspomóc odchudzanieLink do live o Akkermansia muciniphila: https://www.instagram.com/p/CuU8O2sMVCV/?utm_source=ig_web_copy_link&igshid=MzRlODBiNWFlZA==Nataszę znajdziesz w Internecie:Strona: https://nastaya.pl/IG: https://www.instagram.com/dr_nastaya/FB: https://www.facebook.com/drNataszaStaniak/Bibliografia i link do wpisów bibliograficznych:https://nastaya.pl/jak-bakterie-jelitowe-sabotuja-nasze-odchudzanie/ Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity related diseases. Biomed Pharmacother. 2022 Mar;147:112678.Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018 Jul 4;9(4):308-325. Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021 Jul 7;27(25):3837-3850Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013 Sep 6;341(6150):1241214.Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006 Dec 21;444(7122):1027-31Yan J, Sheng L, Li H. Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases? Gut Microbes. 2021 Jan-Dec;13(1):1984104. Vallianou, N., Dalamaga, M., Stratigou, T. et al. Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence. Curr Obes Rep 10, 244–262 (2021).Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, Krakoff J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011 Jul;94(1):58-65.

Would you like a way to support your health that's not only free but will actually save you money?  Are you interested in:  Lowering your blood sugar  Improving your insulin sensitivity  Improving your memory  Lowering your resting heart rate  Improving your sensitivity to your cancer treatments  This episode is for you.   On today's Tuesday Terrain Talk, I'll give you insights that go beyond reducing calories for weight loss.  I'll help you understand what happens when you eat and how becoming mindful and deliberate about how often you eat can benefit your health.  If you struggle with deciding what to eat, starting with when you eat could be a big step in the right direction to support your healthiest body.    Referred to in this episode: Ways to work with Laura:  Better Than Before Breast Cancer Life Coaching Membership  90 Days of Wellness  The Breast Cancer Recovery Facebook Group  Supportive articles and studies:  Current Evidence and Directions for Intermittent Fasting During Cancer Chemotherapy  Fasting and fasting-mimicking diets for chemotherapy augmentation  Intermittent Fasting May Help Cancer Treatments Work Better, Small, Early Study Suggests  Intermittent Fasting: What is it, and how does it work?  How does remodeling of the gut microbiota happen during intermittent fasting?  Prolon Fasting Mimicking 

OT Graphically Library MembershipReference: Camarata, S., Miller, L. J., & Wallace, M. T. (2020). Evaluating sensory integration/sensory processing treatment: issues and analysis. Frontiers in integrative neuroscience, 55.See Figure 1 for Naturalistic Settings Play-Based Approach Model

We go over the Steve Goncalves latest interview on ABC and over the latest defense discovery paperwork. We also sum up and go over the latest (WAS) and (WAT) concerning the #idaho4 case. Idaho murder victim's father shares stark warning to alleged killer: ‘He's gonna realize' 166 Pages of Bryan Kohberger Discovery 4 important item pages State's response to defense's motion to compel “exculpatory” evidence University of Idaho murder victim's family ready to face suspect in court, vows to 'make sure he doesn't get away with it' Kaylee's Bachelors Degree and Stole EXCLUSIVE: Idaho Murder Suspect Bryan Kohberger Gets ‘Disturbing' Love Letters in Jail Idaho students remembered for their 'strength and inspiration' and awarded posthumous degrees States Response to Defendants Motion to Compel Discovery Disclaimer! This is a place to discuss your WAS (wild azz speculation), WAT (wild azz theories) and TAT (tame azz theories) safely without judgment. We encourage you give your tips; anything you have seen with your own eyes or heard with your own ears to law enforcement. Clips are played under the conditions of FAIR USE. This show is for entertainment and or information purposes only. No literal meaning should be taken or inferred. We do not encourage anyone mentioned in this video to be contacted or harassed. We would love to hear from you! Call and leave us up to a 3 min message. Call Us: (325)261-0892 Contact us by email: midnightrad.io101@gmail.com Visit our Website for episodes, articles and merch: ⁠www.midnightrad.io⁠ https://anchor.fm/midnightrad Leave us an audio message here: ⁠https://anchor.fm/midnightrad/message --- Send in a voice message: https://podcasters.spotify.com/pod/show/midnightrad/message Support this podcast: https://podcasters.spotify.com/pod/show/midnightrad/support

Episode 3: Severe pediatric asthma-beyond standard therapy, the role of current and future therapies including biologics Description: Though severe pediatric asthma only represents from 2 to 5% of the children suffering with this condition, it represents a major share of the cost, resource utilization, and morbidity. It is important that allergists have a good gasp of this condition and how it differs from the adult population. Topics include appropriate workup, comorbidities, steroid burden.   Learning Objectives: Be able to discuss the burden of severe pediatric asthma and issues in optimal medication adherence in this population Be able to evaluate the child with severe asthma and screen for corticosteroid overuse in and remedies to decrease it in this population Be able to interpret the mechanisms of action, applicable pediatric population, dosing, outcome data, and adverse effects of current and future treatments beyond standard therapy in severe pediatric asthma References:               Perry, R., Braileanu, G., Palmer, T. et al. The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence. PharmacoEconomics 37, 155–167 (2019). Yao T, Wang J, Chang S, et al. Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children. JAMA Pediatr. Published online April 19, 2021. Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, et al. Changing paradigms in the treatment of severe asthma: the role of biologic therapies. J Allergy Clin Immunol Pract 2017;5:S1–S14. Licari, A., Manti, S., Castagnoli, R. et al. Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives. Pediatr Drugs 21, 215–237 (2019)

Episode 1: Severe pediatric asthma-burden of disease, adherence issues, and comorbidities   Description: Though severe pediatric asthma only represents from 2 to 5% of the children suffering with this condition, it represents a major share of the cost, resource utilization, and morbidity. It is important that allergists have a good gasp of this condition and how it differs from the adult population. Topics include appropriate workup, comorbidities, steroid burden.   Learning Objectives: Be able to discuss the burden of severe pediatric asthma and issues in optimal medication adherence in this population Be able to evaluate the child with severe asthma and screen for corticosteroid overuse in and remedies to decrease it in this population Be able to interpret the mechanisms of action, applicable pediatric population, dosing, outcome data, and adverse effects of current and future treatments beyond standard therapy in severe pediatric asthma References:               Perry, R., Braileanu, G., Palmer, T. et al. The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence. PharmacoEconomics 37, 155–167 (2019). Yao T, Wang J, Chang S, et al. Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children. JAMA Pediatr. Published online April 19, 2021. Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, et al. Changing paradigms in the treatment of severe asthma: the role of biologic therapies. J Allergy Clin Immunol Pract 2017;5:S1–S14. Licari, A., Manti, S., Castagnoli, R. et al. Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives. Pediatr Drugs 21, 215–237 (2019)

Episode 2:       Severe pediatric asthma-evaluation of the child, diagnostic testing, assessing steroid side effects   Description: Though severe pediatric asthma only represents from 2 to 5% of the children suffering with this condition, it represents a major share of the cost, resource utilization, and morbidity. It is important that allergists have a good gasp of this condition and how it differs from the adult population. Topics include appropriate workup, comorbidities, steroid burden.   Learning Objectives: Be able to discuss the burden of severe pediatric asthma and issues in optimal medication adherence in this population Be able to evaluate the child with severe asthma and screen for corticosteroid overuse in and remedies to decrease it in this population Be able to interpret the mechanisms of action, applicable pediatric population, dosing, outcome data, and adverse effects of current and future treatments beyond standard therapy in severe pediatric asthma References:               Perry, R., Braileanu, G., Palmer, T. et al. The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence. PharmacoEconomics 37, 155–167 (2019). Yao T, Wang J, Chang S, et al. Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children. JAMA Pediatr. Published online April 19, 2021. Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, et al. Changing paradigms in the treatment of severe asthma: the role of biologic therapies. J Allergy Clin Immunol Pract 2017;5:S1–S14. Licari, A., Manti, S., Castagnoli, R. et al. Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives. Pediatr Drugs 21, 215–237 (2019)

I describe a recent and insane "school shooter drill"; a federal lawsuit against an entire school board and others for covering up the sexual sexual assault of students at the hands of a teacher; the backtracking from the universities that forced the jabs, how the evidence is on the wall and people can't see it—and how all of this is helping lead to the moral and financial collapse of the American education system.   Homework:  https://rumble.com/v2l3njq-derek-johnson-continuity-of-government-is-in-place-military-in-control-scar.html

Go online to PeerView.com/KZP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Learn how to apply the evidence that supports modern therapeutics in conjunction with allogeneic hematopoietic stem cell (HCT)! This "Clinical Consults" activity features an expert-led, case-centered discussion focusing on therapeutic decision-making in HCT-eligible acute myeloid leukemia (AML). Throughout, the panelists weigh in on topics such as how to incorporate targeted options into the management of HCT-eligible patients based on FLT3 or TP53 mutations, selection of appropriate postremission maintenance, and the use of novel conditioning to expand access to HCT for AML populations with unmet medical needs. Upon completion of this activity, participants should be better able to: Characterize baseline disease- and patient-related features that can inform prognosis and facilitate treatment decisions for transplant-eligible patients with AML; Integrate novel therapies into induction, consolidation, and maintenance/postremission regimens for transplant-eligible patients with AML in accordance with updated safety and efficacy evidence and current guidelines; and Incorporate novel therapies into treatment plans for patients with relapsed/refractory AML, including as pretransplant conditioning or as salvage options post-transplant

Go online to PeerView.com/KZP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Learn how to apply the evidence that supports modern therapeutics in conjunction with allogeneic hematopoietic stem cell (HCT)! This "Clinical Consults" activity features an expert-led, case-centered discussion focusing on therapeutic decision-making in HCT-eligible acute myeloid leukemia (AML). Throughout, the panelists weigh in on topics such as how to incorporate targeted options into the management of HCT-eligible patients based on FLT3 or TP53 mutations, selection of appropriate postremission maintenance, and the use of novel conditioning to expand access to HCT for AML populations with unmet medical needs. Upon completion of this activity, participants should be better able to: Characterize baseline disease- and patient-related features that can inform prognosis and facilitate treatment decisions for transplant-eligible patients with AML; Integrate novel therapies into induction, consolidation, and maintenance/postremission regimens for transplant-eligible patients with AML in accordance with updated safety and efficacy evidence and current guidelines; and Incorporate novel therapies into treatment plans for patients with relapsed/refractory AML, including as pretransplant conditioning or as salvage options post-transplant

Go online to PeerView.com/KZP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Learn how to apply the evidence that supports modern therapeutics in conjunction with allogeneic hematopoietic stem cell (HCT)! This "Clinical Consults" activity features an expert-led, case-centered discussion focusing on therapeutic decision-making in HCT-eligible acute myeloid leukemia (AML). Throughout, the panelists weigh in on topics such as how to incorporate targeted options into the management of HCT-eligible patients based on FLT3 or TP53 mutations, selection of appropriate postremission maintenance, and the use of novel conditioning to expand access to HCT for AML populations with unmet medical needs. Upon completion of this activity, participants should be better able to: Characterize baseline disease- and patient-related features that can inform prognosis and facilitate treatment decisions for transplant-eligible patients with AML; Integrate novel therapies into induction, consolidation, and maintenance/postremission regimens for transplant-eligible patients with AML in accordance with updated safety and efficacy evidence and current guidelines; and Incorporate novel therapies into treatment plans for patients with relapsed/refractory AML, including as pretransplant conditioning or as salvage options post-transplant

Go online to PeerView.com/KZP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Learn how to apply the evidence that supports modern therapeutics in conjunction with allogeneic hematopoietic stem cell (HCT)! This "Clinical Consults" activity features an expert-led, case-centered discussion focusing on therapeutic decision-making in HCT-eligible acute myeloid leukemia (AML). Throughout, the panelists weigh in on topics such as how to incorporate targeted options into the management of HCT-eligible patients based on FLT3 or TP53 mutations, selection of appropriate postremission maintenance, and the use of novel conditioning to expand access to HCT for AML populations with unmet medical needs. Upon completion of this activity, participants should be better able to: Characterize baseline disease- and patient-related features that can inform prognosis and facilitate treatment decisions for transplant-eligible patients with AML; Integrate novel therapies into induction, consolidation, and maintenance/postremission regimens for transplant-eligible patients with AML in accordance with updated safety and efficacy evidence and current guidelines; and Incorporate novel therapies into treatment plans for patients with relapsed/refractory AML, including as pretransplant conditioning or as salvage options post-transplant

Go online to PeerView.com/KZP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Learn how to apply the evidence that supports modern therapeutics in conjunction with allogeneic hematopoietic stem cell (HCT)! This "Clinical Consults" activity features an expert-led, case-centered discussion focusing on therapeutic decision-making in HCT-eligible acute myeloid leukemia (AML). Throughout, the panelists weigh in on topics such as how to incorporate targeted options into the management of HCT-eligible patients based on FLT3 or TP53 mutations, selection of appropriate postremission maintenance, and the use of novel conditioning to expand access to HCT for AML populations with unmet medical needs. Upon completion of this activity, participants should be better able to: Characterize baseline disease- and patient-related features that can inform prognosis and facilitate treatment decisions for transplant-eligible patients with AML; Integrate novel therapies into induction, consolidation, and maintenance/postremission regimens for transplant-eligible patients with AML in accordance with updated safety and efficacy evidence and current guidelines; and Incorporate novel therapies into treatment plans for patients with relapsed/refractory AML, including as pretransplant conditioning or as salvage options post-transplant

Go online to PeerView.com/KZP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Learn how to apply the evidence that supports modern therapeutics in conjunction with allogeneic hematopoietic stem cell (HCT)! This "Clinical Consults" activity features an expert-led, case-centered discussion focusing on therapeutic decision-making in HCT-eligible acute myeloid leukemia (AML). Throughout, the panelists weigh in on topics such as how to incorporate targeted options into the management of HCT-eligible patients based on FLT3 or TP53 mutations, selection of appropriate postremission maintenance, and the use of novel conditioning to expand access to HCT for AML populations with unmet medical needs. Upon completion of this activity, participants should be better able to: Characterize baseline disease- and patient-related features that can inform prognosis and facilitate treatment decisions for transplant-eligible patients with AML; Integrate novel therapies into induction, consolidation, and maintenance/postremission regimens for transplant-eligible patients with AML in accordance with updated safety and efficacy evidence and current guidelines; and Incorporate novel therapies into treatment plans for patients with relapsed/refractory AML, including as pretransplant conditioning or as salvage options post-transplant

This episode's guest is Dr. Matthew Nagra, ND. Dr. Nagra is a Naturopathic Doctor devoted to bringing the most up-to-date evidence-based nutrition information to his patients at his clinic in Vancouver and to the public through his social media channels. He has been a contributing author on multiple textbooks from Professional Health Systems, including their Nutrition textbook. He is also a public speaker, and is well-known for his content across multiple social media platforms, where he often tackles misinformation around diet and dives deep into the latest nutrition research.  We reviewed the latest evidence on some of the most debated and controversial topics in nutrition. Our conversation revolved around topics such as the data on dietary protein source and quality, fats, low carbohydrate diets, lectins and other anti-nutrients, artificial sweeteners, and many other topics.   References: Carb quality: - https://pubmed.ncbi.nlm.nih.gov/30638909/    Food groups and mortality: - https://pubmed.ncbi.nlm.nih.gov/28446499/    Low carb/keto: - https://pubmed.ncbi.nlm.nih.gov/24500611/  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001988/    Antinutrients: - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600777/    Protein:  - https://pubmed.ncbi.nlm.nih.gov/29722584/  - https://pubmed.ncbi.nlm.nih.gov/33599941/  - https://pubmed.ncbi.nlm.nih.gov/25628520/  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358922/  - https://pubmed.ncbi.nlm.nih.gov/33261645/  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698202/    Saturated fat vs other fats: - https://apps.who.int/iris/handle/10665/246104 - https://pubmed.ncbi.nlm.nih.gov/28444290/ - https://www.gov.uk/government/publications/saturated-fats-and-health-sacn-report   Alcohol guidelines: - https://ccsa.ca/canadas-guidance-alcohol-and-health Join the FREE 5-Day Better Brain Nutrition Challenge! BetterBrainNutritionChallenge.com Link to Dr. Nagra's website: https://drmatthewnagra.com Dr. Nagra's Social media: Instagram: https://www.instagram.com/dr.matthewnagra/ Facebook: https://www.facebook.com/dr.matthewnagra/ Follow us: Join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com

In this episode, I discuss the most current research as it relates to exercise-associated muscle cramping, or simply cramping during exercise. Cramping during exercise is a very often misunderstood topic and one fraught with misinformation. My goal with this episode is to dispel some common misbeliefs surrounding muscle cramping during exercise, provide an overview of the progression of proposed theories attempting to explain muscle cramping during exercise, and the best prevention approach for muscle cramping during exercise based on the most current research evidence we have. In this episode, I reference a figure and a checklist. Both of these items can be found within the link below and also within the reference cited below.Muscle Cramping During Exercise: What Does the Latest Evidence Say Regarding the Cause and Treatment of Cramping?:https://www.peakendurancesolutions.com/vo2-max-forum/the-vo2-max-forum/muscle-cramping-during-exercise-what-does-the-latest-evidence-say-regarding-the-cause-and-treatment-of-crampingReferences:1. Miller KC, McDermott BP, Yeargin SW, Fiol A, Schwellnus MP. An Evidence-Based Review of the Pathophysiology, Treatment, and Prevention of Exercise-Associated Muscle Cramps. Journal of Athletic Training. 2022 Jan;57(1):5-15.Buzzsprout - Let's get your podcast launched! Start for FREEDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showWebsite: www.peakendurancesolutions.comEmail: peakendurancesolutions@outlook.comInstagram: @ryaneckert_coach

I wanted to kick off the new year discussing ways we can optimize our health. We don't often think about our overall health – instead we think about what the number on the scale says. I'm going to give you my top 7 strategies to improve your health. I will preface this by saying that I believe we need all of these 7, not just to pick one or two and run. Then, we will get into supplements that can be very beneficial as an adjunct to these 7 key strategies. Just a quick disclaimer that this podcast is meant for educational purposes only and is not meant to diagnose or be a substitute for medical advice from your practitioner. **Follow me on Instagram: https://www.instagram.com/thefunctionalnursepractitioner/ ** Level up your products: https://www.ewg.org/ewgverified/ **Interesting articles for more information** Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551574/pdf/nutrients-12-02873.pdf Determinants of weight loss maintenance: a systematic review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416131/pdf/OBR-20-171.pdf World Heart Federation Policy Brief: Front-Of-Pack Labelling: Unhealthy Changes in the Global Food System: https://pubmed.ncbi.nlm.nih.gov/33150135/ Human health implications of organic food and organic agriculture: a comprehensive review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658984/pdf/12940_2017_Article_315.pdf Glyphosate, a chelating agent—relevant for ecological risk assessment?: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823954/pdf/11356_2017_Article_1080.pdf Nanovesicles from Organic Agriculture-Derived Fruits and Vegetables: Characterization and Functional Antioxidant Content: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347793/pdf/ijms-22-08170.pdf Alpha-lipoic acid: https://www.mountsinai.org/health-library/supplement/alpha-lipoic-acid calcium glucarate: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate

✅ Why is the recommendation to go on a low-salt diet a scam? In this video, I'll reveal why the science doesn't support this, and how countries that live the longest also eat lots of salt. This is the exact opposite of what our health "experts" recommend. You'll be shocked by the chart I'm going to show you. ✅ Support the Doctor Park Locals.com community. Help me to write my book. https://doctorpark.locals.com/support... ✅ DOWNLOAD TRANSCRIPT https://doctorstevenpark.com/wp-conte... ✅ CHAPTERS: 00:00 Introduction 01:15 Most people don't respond to salt 01:37 The top 3 countries that live the longest also eat very high levels of salt 02:42 Counties that eat more salt live the longest 02:57 Countries that eat less salt die earlier 03:13 Salt intake and U-shaped mortality curve at both extremes ✅ LINKS MENTIONED Salt sensitivity of blood pressure in humans https://www.ahajournals.org/doi/full/... Coronary heart disease age-related death https://www.worldlifeexpectancy.com/c... 11 Countries That Consume the Most Salt https://www.insidermonkey.com/blog/11... Sodium intake, life expectancy, and all-cause mortality https://europepmc.org/backend/ptpmcre... Sodium Intake and Health: What Should We Recommend Based on the Current Evidence? https://www.mdpi.com/2072-6643/13/9/3232 ✅ PRODUCTS & SERVICES How you can sleep great and have more energy and mental clarity. Dr. Park's The 90-Day Sleep Diet. http://the90daysleepdiet.com/ Want to un-stuff your stuffy nose? Read the e-book, How to Un-stuff Your Stuffy Nose: Breathe Better, Lose Weight, Sleep Great (PDF) https://www.unstuffyourstuffynose.com... Your Health Transformation Workbook: Refresh, Restore, & Rejuvenate Your Life (online format) https://doctorpark.samcart.com/produc... Want to have more energy, sleep better, have less pain, and enjoy living again? Reserve a Virtual Coaching session today with Dr. Park https://doctorpark.samcart.com/produc... ✅ CONNECT WITH DR. PARK DoctorStevenPark.com doctorpark@doctorstevenpark.com For inquiries about interviews or presentations, please contact Dr. Park through his website at doctorstevenpark.com. ✅ DISCLAIMER This video is for general educational and informational purposes only. It is not to be taken as a substitute for professional medical advice, diagnosis, or treatment. Please consult with your doctor first before making any changes to your health, exercise, nutrition, or dietary regimen. Certain product links above will take you to Amazon.com. If you then go on to buy the product, Amazon will provide me with a small commission, which will not cost you anything.

"Prolotherapy: Background History, Mechanism of Action, and Current Evidence," by Yogesh Taheem, MD, Anesthesiology Resident, Rush University Medical Center; and Tolga Suvar, MD, Assistant Professor, Department of Anesthesiology, Rush Medical College; both in Chicago, Illinois. From ASRA Pain Medicine News, August 2022. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.   

Are you dealing with long haul symptoms such as fatigue, brain fog, or digestive distress? Want to understand the COVID-microbiome connection? In need of a reset to put long haul symptoms in the past? Tune in to hear us explore the reasons some deal with long term effects including microbiome imbalance, oxidative stress, and more.    In this episode, we discuss the 50+ reported long term effects of COVID that may impact daily life. Learn how an imbalance microbiome can predispose to COVID severity, and how lasting changes in the gut flora can drive long haul symptoms and unfavorable digestive changes. Plus hear up to date recommendations on reducing viral replication and supporting your system should you get the dreaded C-word yet again in this endemic phase!    Also in this episode:  Beat the Bloat Program $10 Off with code BTB10 How Common is Long Haul?Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT Covid-19 Breakthrough Infections in Vaccinated Health Care Workers Symptoms of Long COVIDMore than 50 Long-term effects of COVID-19: a systematic review and meta-analysis The Microbiome COVID ConnectionAlterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 Six-month follow-up of gut microbiota richness in patients with COVID-19 Supporting the Microbiome Post COVIDProbiotic Challenge Herbal Immune  Berberine Boost GI Clean Up Beat the Bloat Bundle Beat the Bloat Program + Ebook  Food as Medicine Support for Good Gut FloraEpisode 305 Trends in Keto + KetoCon Recap PhytoFiber Probiotic SupplementationRebuild Spectrum Probiotic Targeted Strength Probiotic Oxidative Stress as a Driver of LonghaulBroccoDetox 10 Day Detox Bone Broth Fasting Grassfed Whey Cellular Antiox Reducing Viral ReplicationBio-C Plus Inflammazyme The Stress Immune ConnectionCalm and Clear Adaptogen Boost GI Lining Support The Importance of SleepSleep Support The Impact of Universal MaskingCorrelation Between Mask Compliance and Covid 19 Outcomes   Sponsors for this episode:  This episode is sponsored by FOND Bone Broth Tonics, Your Sous Chef in a Jar. FOND is slow simmered and lovingly tended from simmer to seal. They partner with organic farms and hand-pick and pair ingredients to optimize absorption and taste. Use code ALIMILLERRD to save at fondbonebroth.com.

How to manage pain for patients with osteoarthritis? Drs Argoff and Hochberg discuss. Credit available for this activity expires: 6/16/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974292?src=mkm_podcast_addon_974292

This episode will review racial, ethnic, socioeconomic, and geographic disparities related to atopic dermatitis. Disparities in Atopic Dermatitis Miniseries Host: Payel Gupta, MD, FACAAI Expert: Anil Nanda, MD, FACAAI Expert: Andrew Alexis, MD, MPH Expert: Marcella Aquino, MD, FACAAI The miniseries is hosted by Payel Gupta, MD,  a triple board-certified specialist and the Medical Director for Allergy, Asthma, Immunology & ENT at LifeMD.com. She is practicing in New York City and is an assistant clinical professor at SUNY Downstate Medical Center and Clinical Instructor at Mount Sinai Medical Center.  She is a volunteer national spokesperson for the American Lung Association and co-host of The Itch Podcast. Joining her are Anil Nanda, MD, who is in private community practice at the Asthma and Allergy Center in Lewisville and Flower Mound, Texas and is Clinical Associate Professor of Medicine, at the Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, TX; Andrew F. Alexis, MD, MPH, who is the Vice-Chair for Diversity and Inclusion for the Department of Dermatology and Professor of Clinical Dermatology at Weill Cornell Medical College in New York City. He is the former Chair of the Department of Dermatology at Mount Sinai Morningside and Mount Sinai West. Having served as Director of the first-of-its-kind Skin of Color Center for over 15 years, his work has helped to advance patient care, research, and education pertaining to dermatologic disorders that are prevalent in populations with skin of color; and Marcella Aquino, MD, who is an Associate Professor of Pediatrics at the Warren Alpert Medical School of Brown University and staff at Rhode Island Hospital/Hasbro Children's Hospital. Her interests include allergic skin diseases particularly allergic contact dermatitis, atopic dermatitis, and drug allergy. She has presented on these topics at national meetings and published in textbooks and peer reviewed journals with a focus on contact dermatitis including patch testing, the role of contact dermatitis in atopic dermatitis patients, drug allergy challenges/desensitizations and the use of simulation for the instruction of anaphylaxis/allergic emergencies. Dr. Aquino was awarded an implementation grant by the ACAAI Foundation looking a multi-level contributing factors to racial and ethnic disparities in urban children in asthma and atopic dermatitis. This podcast series is supported by Pfizer.  

The food we put in our bodies affects more than just our waistlines, it also affects our abilities to focus and perform our jobs well. But what many people don't know is that improving your focus and performance doesn't have to mean overhauling your entire diet. By adding a few superfoods to your daily menu, you can greatly improve your cognitive functions, because often your best self is just a few bites away. Join OneDigital in this episode of Byte-Sized Benefits to learn more about superfoods that can help you improve your focus at work.  The Effect of Caffeine on Energy Balance The Potential for Military Diets to Reduce Depression, Suicide, and Impulsive Aggression: A Review of Current Evidence for Omega-3 and Omega-6 Fatty Acids Nutrients and Bioactives in Green Leafy Vegetables and Cognitive Decline Effects of a Mixed Berry Beverage on Cognitive Functions and Cardiometabolic Risk Markers; A Randomized Cross-Over Study in Healthy Older Adults Communicating the Nutrition and Health Benefits of Avocados

In this episode, Marc and Mo are joined by special guest Zain Chagla, MD (Associate Professor of Medicine and Director of Infection Control at McMaster University and St. Joseph’s Hospital) in a timely discussion of the current landscape and evolving strategies related to the ongoing COVID-19 pandemic, with a focus on the Omicron variant as well as the interface between social media and science. OrthoJOE Mailbag: feedback, comments, and suggestions from our audience can be sent to orthojoe@jbjs.org Links: Vannabouathong C, Devji T, Ekhtiari S, Chang Y, Phillips SA, Zhu M, Chagla Z, Main C, Bhandari M. Novel Coronavirus COVID-19: Current Evidence and Evolving Strategies. J Bone Joint Surg Am. 2020 May 6;102(9):734-744. doi: 10.2106/JBJS.20.00396. https://jbjs.org/reader.php?id=206110&rsuite_id=2387011&native=1&source=The_Journal_of_Bone_and_Joint_Surgery/102/9/734/fulltext&topics=if%2Boe#info López-Medina E, López P, Hurtado IC, Dávalos DM, Ramirez O, Martínez E, Díazgranados JA, Oñate JM, Chavarriaga H, Herrera S, Parra B, Libreros G, Jaramillo R, Avendaño AC, Toro DF, Torres M, Lesmes MC, Rios CA, Caicedo I. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071. https://pubmed.ncbi.nlm.nih.gov/33662102/

In this episode, Marc and Mo are joined by special guest Gerard Slobogean, MD (Associate Professor and Director of Clinical Research, Department of Orthopaedics, University of Maryland School of Medicine) in an insightful conversation on the current issues and challenges related to the treatment of, and research into, open fractures. OrthoJOE Mailbag: feedback, comments, and suggestions from our audience can be sent to orthojoe@jbjs.org Links: Chang Y, Bhandari M, Zhu KL, Mirza RD, Ren M, Kennedy SA, Negm A, Bhatnagar N, Naji FN, Milovanovic L, Fei Y, Agarwal A, Kamran R, Cho SM, Schandelmaier S, Wang L, Jin L, Hu S, Zhao Y, Lopes LC, Wang M, Petrisor B, Ristevski B, Siemieniuk RAC, Guyatt GH. Antibiotic Prophylaxis in the Management of Open Fractures: A Systematic Survey of Current Practice and Recommendations. JBJS Rev. 2019 Feb;7(2):e1. doi: 10.2106/JBJS.RVW.17.00197. PMID: 30724762. https://jbjs.org/reader.php?id=205004&rsuite_id=1938010&native=1&source=JBJS_Reviews/7/2/e1/abstract&topics=ta#info Foote CJ, Tornetta P 3rd, Reito A, Al-Hourani K, Schenker M, Bosse M, Coles CP, Bozzo A, Furey A, Leighton R; GOLIATH Investigators. A Reevaluation of the Risk of Infection Based on Time to Debridement in Open Fractures: Results of the GOLIATH Meta-Analysis of Observational Studies and Limited Trial Data. J Bone Joint Surg Am. 2021 Feb 3;103(3):265-273. doi: 10.2106/JBJS.20.01103. Erratum in: J Bone Joint Surg Am. 2021 Mar 17;103(6):e25. PMID: 33298796. https://www.jbjs.org/reader.php?id=207441&rsuite_id=2681010&native=1&topics=ta&source=The_Journal_of_Bone_and_Joint_Surgery%2F103%2F3%2F265%2Ffulltext#content/contributor_reference_11 PREP-IT Trial: https://www.prepittrial.com/ Stennett CA, O'Hara NN, Sprague S, Petrisor B, Jeray KJ, Leekha S, Yimgang DP, Joshi M, O'Toole RV, Bhandari M, Slobogean GP; FLOW Investigators. Effect of Extended Prophylactic Antibiotic Duration in the Treatment of Open Fracture Wounds Differs by Level of Contamination. J Orthop Trauma. 2020 Mar;34(3):113-120. doi: 10.1097/BOT.0000000000001715. PMID: 32084088; PMCID: PMC8077225. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077225/

Off the back of the Society for Acupuncture Research (SAR) conference (2021), in this episode Nick and Spod will be discussing the current state of the evidence-base for acupuncture. They will be exploring questions including:Where is the evidence strongest and where is there potential?What are some of the key issues in the field such as placebo?Where does the future of acupuncture research lie?References from the show:Efficacy for chronic pain (MacPherson and Charlesworth, 2020; Vickers et al., 2018):https://pubmed.ncbi.nlm.nih.gov/29198932/ and https://pubmed.ncbi.nlm.nih.gov/33362893/Efficacy for migraines (Zhao et al., 2017): https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2603492UK NICE guidelines chronic pain (National Institute for Clinical Excellence NICE, 2021):https://www.nice.org.uk/guidance/ng193/evidence/acupuncture-in-people-with-chronic-primary-pain-pdf-9075291805Acupuncture and mechanical placebos (Kaptchuk, 2020): https://pubmed.ncbi.nlm.nih.gov/33362886/Future directions for acupuncture research (Schnyer and Hullender Rubin, 2020): https://pubmed.ncbi.nlm.nih.gov/33362894/Acupuncture reducing risk of coronary heart disease in osteoarthritis patients (Ton et al., 2021): https://pubmed.ncbi.nlm.nih.gov/32744906/Acupuncture and anti-inflammatory pathways (Liu et al., 2020): https://pubmed.ncbi.nlm.nih.gov/32791039/Acupuncture for carpal tunnel syndrome (Maeda et al., 2017): https://pubmed.ncbi.nlm.nih.gov/28334999/Acupuncture and fibromyalgia RCT and neuroimaging (Mawla et al., 2021): https://pubmed.ncbi.nlm.nih.gov/33314799/

Sponsored by BetterHelp. Clinicians, sign up with BetterHelp to increase your bookings and work from teh comfort of your own home. https://hasofferstracking.betterhelp.com/aff_c?offer_id=20&aff_id=2373 Co-Occurring Disorders Current Evidence Based Treatments Dr. Dawn-Elise Snipes Objectives ~ Review current research on evidence based and promising practices for Co-Occurring Disorders Intro ~ Most people with addictions also have other co-occurring […] Learn more about your ad choices. Visit megaphone.fm/adchoices

Regenerative Medicine is no pseudoscience- it has been used by both senior citizens as well as the word's top athletes such as Troy Polamalu and Ben Roethlisberger. But what IS IT, exactly? I wanted to bring the most well-versed and experienced healthcare professional I know to break down the ins and out of what regenerative medicine is, how it can help you and your patients, and applications for its role in our ever-expanding society of healthcare! Mike Leone is a physician assistant practicing in physical medicine & rehabilitation and the cutting-edge field of regenerative orthopedics at Choice Restorative Medicine. He graduated from W&J College undergrad and got his Masters in Physician Assistant Studies at Chatham University in Pittsburgh. Mike is passionate about alternative ways to approach pain management and wants to educate the community on the healing power of regenerative medicine. Listen in as we dive into: - What is regenerative medicine? - What can be treated with regenerative medicine? - How can you get treated? - How does this tie into traditional pain management therapies? - Resources for further learning about regenerative medicine Resources Mentioned In This Podcast: -Research Book: https://neilriordanbooks.com/mesenchymal-stem-cells -Seminal Paper on the Physiological Function of Adult Stem Cells: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144500 -Most Up-to-Date Review on PRP and Its Role Based on Current Evidence: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632954 Like The Fit Pharmacist on Facebook: www.facebook.com/thedietdocpittsburgh Host: Dr. Adam Martin, PharmD, ACSM-cPT LinkedIn: www.linkedin.com/in/thefitpharmd Instagram: www.instagram.com/thefitpharmacist Website: thefitpharmacist.com YouTube Channel: www.youtube.com/channel/UCMLjmxSZ_RZYCfwt2QkD5zA Guest: Mike Leone, PA-C Facebook: https://www.facebook.com/ChiroChoice Instagram: https://www.instagram.com/choicechiro8199 Twitter: https://twitter.com/chirochoice Website: https://choicemedpgh.com